Taiwan clears VUNO's AI fundus analysis tool
South Korean firm VUNO has gained the approval of Taiwan's Food and Drug Administration to market its AI fundus analysis software.
VUNO Med-Fundus AI analyses images of the fundus to quickly detect locations of lesions indicative of retinal diseases, including diabetic retinopathy, macular disease and glaucoma.
This latest certification follows Taiwan...
Neurowyzr, a developer of neuroscience-based digital solutions in Singapore, has partnered with primary healthcare provider Parkway Shenton to launch its online brain screening tool.
WHAT IT DOES
The company's Digital Brain Function Scan (DBFS) is a medical-grade brain health assessment that can be done on the web upon prescription from a doctor. Registered with the Singapore Health Sciences...
A digital brain assessment tool by ASX-listed neuroscience tech company Cogstate is coming to Taiwan and Hong Kong.
On Thursday, the Cogstate announced that CogMate, the global multilingual version of its NouKNOW digital tool for self-assessment of brain performance, will be distributed by pharmaceutical firm Eisai in the two Asian markets.
WHAT IT DOES
Accessible via web and mobile devices,...
